Tiffany A Traina

Tiffany A Traina

UNVERIFIED PROFILE

Are you Tiffany A Traina?   Register this Author

Register author
Tiffany A Traina

Tiffany A Traina

Publications by authors named "Tiffany A Traina"

Are you Tiffany A Traina?   Register this Author

50Publications

1211Reads

38Profile Views

Emerging Novel Therapeutics in Triple-Negative Breast Cancer.

Adv Exp Med Biol 2019 ;1152:377-399

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-20301-6_20DOI Listing
September 2019

Male breast cancer: a disease distinct from female breast cancer.

Breast Cancer Res Treat 2019 Jan 28;173(1):37-48. Epub 2018 Sep 28.

Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4921-9DOI Listing
January 2019

Reply to K.S. Shohdy et al.

J Clin Oncol 2018 08 30;36(23):2458-2459. Epub 2018 May 30.

Tiffany A. Traina, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; and Javier Cortes, Ramon y Cajal University Hospital, Madrid, and Vall d'Hebron Institute of Oncology and Baselga Oncological Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.8349
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.8349DOI Listing
August 2018

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.

J Clin Oncol 2018 03 26;36(9):884-890. Epub 2018 Jan 26.

Tiffany A. Traina and Ayca Gucalp, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Kathy Miller, Indiana University Simon Cancer Center, Indianapolis, IN; Denise A. Yardley, Tennessee Oncology, Nashville; Lee S. Schwartzberg, The West Clinic, Memphis, TN; Janice Eakle, Florida Cancer Specialists, Fort Myers, FL; Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology, Dallas, TX; William Gradishar, Northwestern University Feinberg School of Medicine; Rita Nanda, University of Chicago, Chicago; Joyce Steinberg, Astellas Pharma, Northbrook, IL; Peter Schmid, Barts Cancer Institute, Queen Mary University London, London, United Kingdom; Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Catherine Kelly, All Ireland Collaborative Oncology Research Group, Dublin, Ireland; Ahmad Awada, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium; Laura Garcia-Estevez, Centro Integral Oncologico Clara Campal, Hospital Madrid Norte-Sanchinarro; Javier Cortes, Ramon y Cajal University Hospital, Madrid, and, Vall d'Hebron Institute of Oncology and Baselga Oncological Institute, Barcelona, Spain; Maureen E. Trudeau, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; and Hirdesh Uppal, Amy Peterson, and Iulia Cristina Tudor, Medivation, San Francisco, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.3495
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.3495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858523PMC
March 2018

Targeting the androgen receptor in triple-negative breast cancer.

Curr Probl Cancer 2016 Mar - Aug;40(2-4):141-150. Epub 2016 Sep 20.

Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01470272163006
Publisher Site
http://dx.doi.org/10.1016/j.currproblcancer.2016.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580391PMC
December 2017

The Androgen Receptor: Is It a Promising Target?

Ann Surg Oncol 2017 Oct 1;24(10):2876-2880. Epub 2017 Aug 1.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5961-9DOI Listing
October 2017

OncoKB: A Precision Oncology Knowledge Base.

JCO Precis Oncol 2017 Jul 16;2017. Epub 2017 May 16.

, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Gynecologic Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Head and Neck Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , , Department of Hematology and Oncology, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA; , Department of R&D and Bioinformatics, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA; , Head and Neck Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Gynecologic Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Sarcoma Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Sarcoma Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA , Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://www.researchgate.net/profile/Debyani_Chakravarty/pub
Web Search
http://ascopubs.org/doi/10.1200/PO.17.00011
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586540PMC
http://dx.doi.org/10.1200/PO.17.00011DOI Listing
July 2017

Androgen receptor-positive, triple-negative breast cancer.

Cancer 2017 05 12;123(10):1686-1688. Epub 2017 Apr 12.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30683DOI Listing
May 2017

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review.

NPJ Breast Cancer 2016 30;2:16006. Epub 2016 Mar 30.

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npjbcancer.2016.6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515341PMC
March 2016

Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Endocr Relat Cancer 2015 Jun 26;22(3):R87-R106. Epub 2015 Feb 26.

Breast Medicine ServiceDepartment of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, New York 10065, USAGenitourinary Oncology ServiceDepartment of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USAWeill Cornell Medical College1300 York Avenue, New York, New York 10065, USA Breast Medicine ServiceDepartment of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, New York 10065, USAGenitourinary Oncology ServiceDepartment of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USAWeill Cornell Medical College1300 York Avenue, New York, New York 10065, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714354PMC
June 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2015 Jun 6;33(17):1902-9. Epub 2015 Apr 6.

Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451173PMC
June 2015

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer.

Breast Cancer (Dove Med Press) 2014 4;6:123-33. Epub 2014 Aug 4.

Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BCTT.S46725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128689PMC
September 2014

Tolerability of chemotherapy in HIV-infected women with breast cancer: are there prognostic implications?

AIDS Patient Care STDS 2014 Jul 19;28(7):358-64. Epub 2014 May 19.

1 Division of Hospital Medicine, New York Presbyterian-Weill Cornell Medical Center , New York City, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/apc.2013.0370DOI Listing
July 2014

Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?

J Clin Oncol 2014 Jun 19;32(18):1909-18. Epub 2014 May 19.

Jeanne S. Mandelblatt, Gheorghe Luta, Meghan McGuckin, Jonathan D. Clapp, Leigh Anne Faul, Claudine Isaacs, Neelima Denduluri, R. Scott Turner, Darlene Howard, and John W. Van Meter, Georgetown University, Washington, DC; Robert A. Stern, Brandon Gavett, Patricia Johnson, and Rebecca A. Silliman, Boston University School of Medicine, Boston, MA; Arti Hurria, City of Hope Comprehensive Cancer Center, Duarte, CA; Paul B. Jacobsen, Moffitt Cancer Center; Patricia Johnson, University of South Florida, Tampa, FL; Neelima Denduluri, Virginia Cancer Specialists, Arlington, VA; Tiffany A. Traina and Tim Ahles, Memorial Sloan-Kettering Cancer Center; Tiffany A. Traina, Weill Medical College of Cornell University, New York, NY; and Andrew Saykin, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.2050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050204PMC
June 2014

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.

Clin Cancer Res 2013 Oct 21;19(19):5505-12. Epub 2013 Aug 21.

Authors' Affiliations: Breast Cancer Medicine Service, Departments of Pathology, Biostatistics, and Radiology, Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York; Dana-Farber Cancer Institute; Massachusetts General Hospital, Boston, Massachusetts; Mayo Clinic, Rochester, Minnesota; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia; University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham, North Carolina; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California; University of Alabama at Birmingham, Birmingham, Alabama; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086643PMC
October 2013

Advances in molecular and clinical subtyping of breast cancer and their implications for therapy.

Surg Oncol Clin N Am 2013 Oct 27;22(4):823-40. Epub 2013 Jul 27.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2013.06.006DOI Listing
October 2013

The role of the androgen receptor in triple-negative breast cancer.

Womens Health (Lond) 2013 Jul;9(4):351-60

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.13.33DOI Listing
July 2013

Triple-negative breast cancer: adjuvant therapeutic options.

Chemother Res Pract 2011 21;2011:696208. Epub 2011 Jun 21.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/696208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265248PMC
August 2012

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.

Cancer 2011 Sep 8;117(18):4125-31. Epub 2011 Mar 8.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25992DOI Listing
September 2011

Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.

Breast Dis 2010 ;31(1):7-18

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BD-2009-0290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228251PMC
June 2011

Determinants of outcome in elderly patients with positive sentinel lymph nodes.

Am J Surg 2011 Jun 8;201(6):734-40. Epub 2010 Jul 8.

Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Evelyn H. Lauder Breast Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2010.02.005DOI Listing
June 2011

Triple-negative breast cancer: role of the androgen receptor.

Cancer J 2010 Jan-Feb;16(1):62-5

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3181ce4ae1DOI Listing
May 2010

Bevacizumab for advanced breast cancer.

Womens Health (Lond) 2010 Jan;6(1):17-25

Breast Cancer Medicine Service, Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.09.71DOI Listing
January 2010

Targeting insulin-like growth factor type 1 receptor in cancer therapy.

Target Oncol 2009 Dec 30;4(4):255-66. Epub 2009 Oct 30.

Department of Medical Oncology, University of Cagliari, 09042, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-009-0123-zDOI Listing
December 2009

PIK3CA mutation associates with improved outcome in breast cancer.

Clin Cancer Res 2009 Aug 11;15(16):5049-59. Epub 2009 Aug 11.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0632DOI Listing
August 2009

Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.

Ann Surg Oncol 2009 Jul 18;16(7):1952-8. Epub 2009 Apr 18.

Department of Surgery, Breast Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-009-0440-6DOI Listing
July 2009

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

Clin Cancer Res 2009 Apr 10;15(7):2472-8. Epub 2009 Mar 10.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1763DOI Listing
April 2009

Bevacizumab in the treatment of metastatic breast cancer.

Authors:
Tiffany A Traina

Oncology (Williston Park) 2009 Apr;23(4):327-32

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
April 2009

Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.

J Clin Oncol 2008 Apr;26(11):1797-802

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.13.8388DOI Listing
April 2008

Bevacizumab for advanced breast cancer.

Hematol Oncol Clin North Am 2007 Apr;21(2):303-19

Department of Medicine, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2007.03.006DOI Listing
April 2007

Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer.

Oncologist 2006 Nov-Dec;11(10):1070-1

Breast Cancer Medicine Service, Department of medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-10-1070DOI Listing
February 2007

Metastatic colon cancer to the ovaries in a Krukenberg-like pattern.

J Clin Oncol 2005 Aug;23(22):5255-6

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.95.111DOI Listing
August 2005

Weekly topotecan for recurrent endometrial cancer: a case series and review of the literature.

Gynecol Oncol 2004 Oct;95(1):235-41

Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.07.035DOI Listing
October 2004

Aromatase inhibitors for hormonal therapy of early-stage breast cancer.

Curr Opin Investig Drugs 2004 Jun;5(6):605-10

Memorial Sloan-Kettering Cancer Center, Department of Medicine, Breast Cancer Medicine Service, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
June 2004